Facebook
Twitter
Telegram
Report an ErrorAltimmune Financial Ratios 2011-2024 | ALT
Annual Financial Ratios Altimmune
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-5.4 | -7.0 | -3.4 | -9.6 | -1.1 | -0.2 | -0.5 | 0.0 | -1.0 | -0.4 | -0.0 | -0.1 | -0.0 |
P/S |
1111.2 | -8715.9 | 75.5 | 57.7 | 4.0 | 0.9 | 2.2 | 0.0 | 0.3 | 0.4 | 0.0 | 0.0 | 0.0 |
EPS |
-1.7 | -1.8 | -2.4 | -1.9 | -1.6 | -15.2 | -4.0 | 3.0 | -0.1 | -0.2 | -0.2 | -0.1 | -0.1 |
EV (Enterprise Value) |
355 M | 503 M | 163 M | 375 M | 22.8 M | -18 M | 29 M | 51.3 M | -9.05 M | -10.9 M | -234 K | -1.27 M | -4.1 M |
EBITDA per Share |
-1.79 | -1.86 | -2.33 | -1.65 | -1.53 | -6.28 | -37.5 | -51.1 | -3.35 | -52.4 | -63.1 | -37 | -71.4 |
EV/EBITDA |
-1.7 | -6.5 | -0.7 | 1.4 | -1.0 | 13.8 | 17.2 | 1.4 | 0.7 | 1.4 | 1.0 | ||
PEG |
0.53 | 0.27 | 0.13 | 0.07 | -0.01 | -0.0 | 0.0 | 0.0 | -0.01 | -0.02 | 0.0 | 0.0 | -0.0 |
P/B |
2.4 | 3.2 | 1.7 | 2.1 | 0.5 | 0.2 | 0.5 | 0.0 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
P/CF |
-6.2 | -9.5 | -4.3 | -13.6 | -2.4 | -0.9 | -1.1 | 0.0 | -1.0 | -0.5 | -0.1 | -0.2 | -0.0 |
ROE % |
-45.57 | -45.72 | -48.76 | -21.71 | -45.08 | -81.08 | -95.37 | 996.21 | -20.67 | -54.48 | -159.74 | -42.15 | -23.96 |
ROA % |
-41.99 | -40.94 | -44.36 | -20.01 | -37.96 | -71.54 | -73.66 | 86.26 | -17.32 | -45.30 | -68.37 | -21.64 | -16.65 |
ROCE % |
-48.33 | -46.21 | -48.67 | -23.51 | -40.82 | -35.63 | -27.24 | -56.60 | -4.84 | -52.54 | -104.79 | -41.08 | -64.47 |
Current Ratio |
12.7 | 9.6 | 11.1 | 19.2 | 10.0 | 8.7 | 6.1 | 1.1 | 7.9 | 7.5 | 2.1 | 2.6 | 4.2 |
DSO |
550.1 | -464.3 | - | 551.8 | 103.8 | 158.0 | 345.6 | 69.7 | 50.6 | 14.6 | 73.9 | 94.9 | 118.8 |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
550.1 | -464.3 | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
550.1 | -464.3 | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Altimmune
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.39 | -0.32 | -0.4 | - | -0.48 | -0.42 | -0.44 | - | -0.81 | -0.6 | -0.38 | - | -0.54 | -0.94 | -0.26 | - | -0.74 | -0.26 | -0.27 | - | -1.73 | -10.29 | -7.49 | - | -61.57 | -0.26 | -0.68 | 1.16 | 1.68 | 0.12 | -0.02 | -0.02 | -0.02 | -0.04 | 0.02 | -0.04 | -0.08 | -0.01 | -0.04 | -0.08 | -0.08 | -0.02 | -0.04 | -0.03 | - | -0.02 | -0.06 | 0.02 | - | -0.05 | -0.04 |
EBITDA per Share |
- | - | -0.44 | - | -0.5 | -0.43 | -0.44 | - | -0.79 | -0.6 | -0.38 | - | -0.55 | -1.02 | -0.48 | - | -0.75 | -0.26 | -0.24 | - | -2.96 | -5.6 | -8.82 | - | -59.7 | -0.32 | -0.65 | -0.8 | -0.07 | -0.02 | -0.02 | -0.01 | -0.03 | -0.03 | 0.02 | -0.04 | -0.07 | -0.02 | -0.04 | -0.1 | -0.06 | -0.03 | -0.02 | -0.03 | -0.04 | -0.03 | -0.03 | -0.02 | -0.06 | -0.06 | -0.1 |
ROE % |
-46.76 | -44.48 | -45.24 | -32.32 | -48.33 | -52.87 | -52.83 | -32.33 | -40.20 | -32.06 | -29.19 | -17.01 | -41.04 | -57.21 | -57.22 | -36.08 | -40.95 | -21.78 | -33.26 | -30.35 | -106.26 | -177.30 | -166.28 | -95.43 | 146.14 | 207.16 | 210.03 | 215.35 | -29.08 | -22.15 | -31.19 | -16.10 | -27.62 | -44.99 | -33.33 | -54.48 | -100.41 | -128.87 | -143.32 | -159.74 | -110.30 | -58.35 | -47.97 | -42.15 | -26.54 | -24.92 | -33.82 | -23.96 | -0.21 | -15.38 | -13.09 |
ROA % |
-42.34 | -40.37 | -41.19 | -29.47 | -43.61 | -47.32 | -47.39 | -29.42 | -36.67 | -29.77 | -26.96 | -15.68 | -35.91 | -48.90 | -48.32 | -30.38 | -34.68 | -18.73 | -29.16 | -26.78 | -74.23 | -117.38 | -105.62 | -59.65 | 142.96 | 177.92 | 178.64 | 185.36 | -23.48 | -17.66 | -25.24 | -17.32 | -23.05 | -37.44 | -27.65 | -45.30 | -59.15 | -61.11 | -66.33 | -68.37 | -48.14 | -26.06 | -22.17 | -21.64 | -12.77 | -11.97 | -19.34 | -16.65 | -0.15 | -10.69 | -9.10 |
ROCE % |
-50.77 | -47.85 | -47.60 | -33.10 | -48.97 | -52.77 | -52.59 | -32.20 | -40.32 | -32.56 | -30.41 | -19.50 | -44.27 | -60.92 | -60.57 | -37.68 | -46.08 | -29.72 | -33.17 | -32.06 | -110.63 | -180.79 | -179.73 | -100.22 | -117.33 | -53.63 | -48.43 | -43.41 | -28.47 | -23.56 | -30.39 | -16.97 | -29.15 | -41.05 | -35.65 | -55.77 | -110.49 | -132.24 | -146.03 | -147.76 | -90.90 | -62.63 | -54.92 | -53.68 | -48.28 | -52.01 | -58.96 | -73.97 | -19.06 | -19.44 | -28.64 |
Current Ratio |
10.3 | 11.8 | 9.7 | 9.6 | 11.1 | 13.7 | 9.9 | 11.1 | 8.6 | 16.1 | 14.8 | 12.7 | 12.7 | 12.7 | 12.7 | 6.3 | 6.3 | 6.3 | 6.3 | 8.5 | 8.5 | 8.5 | 8.5 | 4.4 | 4.4 | 4.4 | 4.4 | 6.2 | 6.2 | 6.2 | 1.1 | 6.2 | 6.2 | 6.2 | 6.2 | 5.9 | 5.9 | 5.9 | 5.9 | 1.8 | 1.8 | 1.8 | 1.8 | 2.0 | 2.0 | 2.0 | 2.0 | 3.3 | 3.3 | 3.3 | 3.3 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 15.0 | 152.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 15.0 | 152.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 15.0 | 152.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency